Pharmacokinetic Models: Overview
Strategies for Assessing and Addressing Confounding
Models of Health Promotion and Illness Prevention I
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Mechanistic Models: Compartment Models in Individual and Population Analysis
Dose-Response Relationship: Overview
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Dec 18, 2025

Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke
Published on: February 12, 2015
Christina Cowan-Ellsberry1, Rosemary T Zaleski2,3, Hua Qian2
1CE2 Consulting, LLC, Cincinnati, OH, USA. cellsberry@gmail.com.
This paper offers recommendations for evaluating consumer product exposure models. It emphasizes consistency in data and definitions to improve prediction accuracy and risk assessment communication.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: